 The production of antibodies has become more complex due to increased demand for high-quality products. As a result, the cost of downstream processing has risen significantly. Variations in impurities present a challenge when developing and optimizing antibody production processes. Existing methods for process optimization and integration are discussed, as well as potential new approaches for future developments. This article was authored by Petra Gromeier, Reinhard Ditz and Johann Strube.